Top Markets
Coin of the day
Roche Holding AG Roche Holding AG

Roche Holding AG

ROG
Pozycja w akcjach #37
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in... Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. The company was founded in 1896 and is headquartered in Basel, Switzerland.
Cena akcji
$419.17
Kapitalizacja rynkowa
$333.66B
Zmiana (1 dzień)
0.50%
Zmiana (1 rok)
14.13%
Kraj
CH
Handel Roche Holding AG (ROG)

Kategoria

Zyski dla Roche Holding AG (ROG)
Zyski w Dec 2025 TTM: $21.39B
Według najnowszych raportów finansowych Roche Holding AG, obecny zysk firmy wynosi $21.39B. W roku 2024 firma osiągnęła zysk w wysokości $13.06B, spadek w porównaniu do zysku z roku 2023, który wynosił $16.74B. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Roche Holding AG od 2000 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
2026 (TTM) $21.39B 0.00%
2025 $21.39B 63.83%
2024 $13.06B -22.02%
2023 $16.74B -5.44%
2022 $17.70B -7.24%
2021 $19.09B -4.57%
2020 $20.00B 16.46%
2019 $17.17B 19.41%
2018 $14.38B 14.44%
2017 $12.57B -1.66%
2016 $12.78B 6.57%
2015 $11.99B -4.81%
2014 $12.60B -23.40%
2013 $16.45B 22.16%
2012 $13.46B 6.42%
2011 $12.65B 5.47%
2010 $12.00B 21.15%
2009 $9.90B -25.31%
2008 $13.26B -2.09%
2007 $13.54B 31.16%
2006 $10.32B 51.54%
2005 $6.81B -18.34%
2004 $8.34B 111.44%
2003 $3.95B -270.88%
2002 $-2.31B -180.67%
2001 $2.86B -50.86%
2000 $5.82B 0.00%
Zyski podobnych firm lub konkurentów
Firma Zyski Różnica w zyskach Kraj